Cargando…

Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study

OBJECTIVES: Smoking is common in patients with cardiovascular disease. Despite strong recommendations for cessation and the existence of efficacious pharmacological and behavioral interventions, cessation rates remain low. Therefore, in this study, we explore perceived facilitators and barriers to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Getz, Vilde, Munkhaugen, John, Lie, Hanne C., Dammen, Toril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074255/
https://www.ncbi.nlm.nih.gov/pubmed/37034951
http://dx.doi.org/10.3389/fpsyg.2023.1060701
_version_ 1785019722338664448
author Getz, Vilde
Munkhaugen, John
Lie, Hanne C.
Dammen, Toril
author_facet Getz, Vilde
Munkhaugen, John
Lie, Hanne C.
Dammen, Toril
author_sort Getz, Vilde
collection PubMed
description OBJECTIVES: Smoking is common in patients with cardiovascular disease. Despite strong recommendations for cessation and the existence of efficacious pharmacological and behavioral interventions, cessation rates remain low. Therefore, in this study, we explore perceived facilitators and barriers to smoking cessation in patients with atherosclerotic cardiovascular disease who have participated in a cessation intervention study. METHODS: Participants (N = 10) from the intervention arm of a randomized controlled study with access to free cessation support and pharmacological aids completed a semi-structured, in-depth telephone interview after a 6-monthfollow-up between October 2021 and July 2022. The interviews were audio recorded, transcribed, and analyzed according to principles of thematic analysis. RESULTS: The mean age was 65.7 (range: 55–79) years, and three of the 10 participants were women. Among the participants, five had quit smoking, three had relapsed, and two were persistent smokers. The themes identified encompassed barriers and facilitators to cessation, both including individual and contextual factors. Barriers included the upsides of smoking, difficult life situations, addiction to smoking, smoking in social circles, perceived lack of support and understanding from health professionals. Facilitators included intrinsic motivation, concerns about the health condition, financial implications, specific behavioral strategies, positive influence from the social environment, and helpful components of the cessation intervention. CONCLUSION: Smokers with cardiovascular disease who have attended a cessation intervention study report several facilitators weighted against barriers, interacting with the intention to cease smoking. The most important potentially modifiable factors of significance for cessation identified may be addressed through motivational interviews and focus groups with other smokers.
format Online
Article
Text
id pubmed-10074255
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100742552023-04-06 Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study Getz, Vilde Munkhaugen, John Lie, Hanne C. Dammen, Toril Front Psychol Psychology OBJECTIVES: Smoking is common in patients with cardiovascular disease. Despite strong recommendations for cessation and the existence of efficacious pharmacological and behavioral interventions, cessation rates remain low. Therefore, in this study, we explore perceived facilitators and barriers to smoking cessation in patients with atherosclerotic cardiovascular disease who have participated in a cessation intervention study. METHODS: Participants (N = 10) from the intervention arm of a randomized controlled study with access to free cessation support and pharmacological aids completed a semi-structured, in-depth telephone interview after a 6-monthfollow-up between October 2021 and July 2022. The interviews were audio recorded, transcribed, and analyzed according to principles of thematic analysis. RESULTS: The mean age was 65.7 (range: 55–79) years, and three of the 10 participants were women. Among the participants, five had quit smoking, three had relapsed, and two were persistent smokers. The themes identified encompassed barriers and facilitators to cessation, both including individual and contextual factors. Barriers included the upsides of smoking, difficult life situations, addiction to smoking, smoking in social circles, perceived lack of support and understanding from health professionals. Facilitators included intrinsic motivation, concerns about the health condition, financial implications, specific behavioral strategies, positive influence from the social environment, and helpful components of the cessation intervention. CONCLUSION: Smokers with cardiovascular disease who have attended a cessation intervention study report several facilitators weighted against barriers, interacting with the intention to cease smoking. The most important potentially modifiable factors of significance for cessation identified may be addressed through motivational interviews and focus groups with other smokers. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10074255/ /pubmed/37034951 http://dx.doi.org/10.3389/fpsyg.2023.1060701 Text en Copyright © 2023 Getz, Munkhaugen, Lie and Dammen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Getz, Vilde
Munkhaugen, John
Lie, Hanne C.
Dammen, Toril
Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study
title Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study
title_full Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study
title_fullStr Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study
title_full_unstemmed Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study
title_short Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study
title_sort barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: a qualitative study
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074255/
https://www.ncbi.nlm.nih.gov/pubmed/37034951
http://dx.doi.org/10.3389/fpsyg.2023.1060701
work_keys_str_mv AT getzvilde barriersandfacilitatorsforsmokingcessationinchronicsmokerswithatheroscleroticcardiovasculardiseaseenrolledinarandomizedinterventiontrialaqualitativestudy
AT munkhaugenjohn barriersandfacilitatorsforsmokingcessationinchronicsmokerswithatheroscleroticcardiovasculardiseaseenrolledinarandomizedinterventiontrialaqualitativestudy
AT liehannec barriersandfacilitatorsforsmokingcessationinchronicsmokerswithatheroscleroticcardiovasculardiseaseenrolledinarandomizedinterventiontrialaqualitativestudy
AT dammentoril barriersandfacilitatorsforsmokingcessationinchronicsmokerswithatheroscleroticcardiovasculardiseaseenrolledinarandomizedinterventiontrialaqualitativestudy